HALs also exhibit significantly higher expression of proliferation markers such as MYC (≥40% in 55% of cases) and BCL2 (≥50% in 65% of cases), meeting the criteria for double-expressor lymphoma (DEL) in a large proportion of cases (9). This evidence concerns the gene BCL2 and lymphoma.